Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx

NCT03923504

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations: Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States

Virginia Commonwealth University Community Memorial Health Center South Hill, Virginia, United States

View Trial Details

Completed

A Registry Study of Participants With Multiple Myeloma in Latin America

NCT03955900

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Fundaleu Buenos Aires, Argentina

Hospital Italiano de Buenos Aires Buenos Aires, Argentina

Instituto de Oncologia Angel H. Roffo Buenos Aires, Argentina

Hospital Privado - Centro Medico de Cordoba Córdoba, Argentina

View all 22 locations

View Trial Details

Completed

Tumor Heterogeneity in Diffuse Large B-cell Lymphoma in Relation to CNS Involvement and Cell-free DNA

NCT04763148

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Department of Hematology, Rigshospitalet Copenhagen, Denmark

View Trial Details

Completed

Continuous Infusion of rhIL-15 for Adults With Advanced Cancer

NCT01572493

Conditions: Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Preschool Wheeze: Inflammation/Infection Guided Management

NCT02517099

Conditions: Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +19 more
Locations: Royal Brompton Hospital London, United Kingdom

View Trial Details

Completed

Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas

NCT02419287

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: ASST-Monza Monza, Italy/MB, Italy

View Trial Details

Completed

Comparing Body Composition Assessment Methods

NCT04610918

Conditions: Body Composition, Gastrointestinal Failure, Hematologic Diseases, +11 more
Locations: Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Completed

Effects of Hericium Erinaceus on Microbiota and Cognition

NCT04939961

Conditions: Cognition Disorders, Cognitive Decline, Mild, Cognitive Dysfunction, +12 more
Locations: University of Primorska, Faculty of Health Sciences Izola, Slovenia

View Trial Details

Completed

HMPL-523 CYP3A/P-gp Inhibitor and CYP Inducer Study

NCT05720767

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: PPD Austin Austin, Texas, United States

View Trial Details

Completed

A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma

NCT03312530

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Fakultni nemocnice Brno; Interni hematologicka a onkologicka klinika Brno, Czechia

Fakultni nemocnice Ostrava; Klinika hematoonkologie Ostrava, Czechia

Univerzita Karlova v Praze a Vseobecna fakultni nemocnice v Praze - 1; Lekarska Fakulta - I Prague, Czechia

Rigshospitalet; Hæmatologisk Klinik København Ø, Denmark

View all 26 locations

View Trial Details